AKTS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is 0.869, suggesting AKTS is Strong Buy.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 20.393, while Aktis Oncology Inc (AKTS) share price is $24.09, making it Buy.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 19.263, while Aktis Oncology Inc (AKTS) share price is $24.09, making it Buy.

Technical Analysis for AKTS

Technical Sentiment Analysis for Aktis Oncology Inc (AKTS) As of 2026-06-18, Aktis Oncology Inc (AKTS) is exhibiting a Strong Buy technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 9 indicators are flashing buy, while 4 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for AKTS stands at 67.302, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.869, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 80.927 and the Commodity Channel Index (CCI) at 207.708 further confirm a 4.2 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, AKTS is trading below its 60-day moving average of $19.263 and below its 200-day long-term moving average of $19.435. Key price levels to watch include the immediate resistance at $24.605 and strong support at $17.595. A break above $24.605 could signal a bull continuation, while falling below $17.595 may test the next Fibonacci floor at $14.418.

Aktis Oncology Inc (AKTS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	10.585	14.418	17.595	21.428	24.605	28.438	31.615
Fibonacci	14.418	17.095	18.75	21.428	24.105	25.76	28.438

Aktis Oncology Inc (AKTS) Technical Indicators

2026-06-18

Name	Value
RSI_14	67.302
STOCHk_14_3_3	80.927
STOCHd_14_3_3	73.862
CCI_20	207.708
AO_5_34	2.87
MOM_10	4.2
MACD_12_26_9	0.869

Aktis Oncology Inc (AKTS) Relative Strength Index (RSI) is 67.302, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Stochastic Oscillator is 80.927, creating a Sell signal.

Aktis Oncology Inc (AKTS) Stochastic RSI is 73.862, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Commodity Channel Index (CCI) is 207.708, creating a Sell signal.

Aktis Oncology Inc (AKTS) Awesome Oscillator is 2.87, creating a Buy signal.

Aktis Oncology Inc (AKTS) Momentum is 4.2, creating a Buy signal.

Aktis Oncology Inc (AKTS) MACD is 0.869, creating a Buy signal.

Aktis Oncology Inc (AKTS) Moving Average

2026-06-18

Period	Simple	Signal
MA_5	22.574	Buy
MA_10	20.773	Buy
MA_20	20.393	Buy
MA_60	19.263	Buy
MA_200	19.435	Buy
MA_250	19.435	Buy

Aktis Oncology Inc (AKTS) 5-Day simple moving average is 22.574, while Aktis Oncology Inc (AKTS) share price is $24.09, making it a Buy.

Aktis Oncology Inc (AKTS) 10-Day simple moving average is 20.773, while Aktis Oncology Inc (AKTS) share price is $24.09, making it a Buy.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 20.393, while Aktis Oncology Inc (AKTS) share price is $24.09, making it a Buy.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 19.263, while Aktis Oncology Inc (AKTS) share price is $24.09, making it a Buy.

Aktis Oncology Inc (AKTS) 200-Day simple moving average is 19.435, while Aktis Oncology Inc (AKTS) share price is $24.09, making it a Buy.

Aktis Oncology Inc (AKTS) 250-Day simple moving average is 19.435, while Aktis Oncology Inc (AKTS) share price is $24.09, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for AKTS?

The overall technical consensus for Aktis Oncology Inc (AKTS) is currently Strong Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 4 sell signals.

What are the key support and resistance levels for Aktis Oncology Inc (AKTS) today?

Based on pivot point calculations, Aktis Oncology Inc (AKTS) has an immediate support level at 17.595 and a major resistance level at 24.605. Traders also monitor the pivot point at 21.428 to determine the intraday trend direction.

Is Aktis Oncology Inc (AKTS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Aktis Oncology Inc (AKTS) is currently 67.302. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Aktis Oncology Inc (AKTS)?

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is 0.869, suggesting AKTS is Strong Buy. This indicator helps identify potential trend reversals or momentum shifts for Aktis Oncology Inc.

How is Aktis Oncology Inc (AKTS) performing relative to its 200-day moving average?

Aktis Oncology Inc (AKTS) is currently trading at $24.09, which is above its 200-day simple moving average of 19.435. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.